Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lichen International (LICN) Common Equity (2021 - 2025)

Lichen International (LICN) has disclosed Common Equity for 4 consecutive years, with $75.6 million as the latest value for Q4 2024.

  • Quarterly Common Equity rose 23.03% to $75.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $75.6 million through Dec 2024, up 23.03% year-over-year, with the annual reading at $75.6 million for FY2024, 23.03% up from the prior year.
  • Common Equity for Q4 2024 was $75.6 million at Lichen International, up from $61.4 million in the prior quarter.
  • The five-year high for Common Equity was $75.6 million in Q4 2024, with the low at $36.8 million in Q4 2021.
  • Average Common Equity over 4 years is $53.7 million, with a median of $51.3 million recorded in 2022.
  • The sharpest move saw Common Equity increased 11.61% in 2022, then soared 49.41% in 2023.
  • Over 4 years, Common Equity stood at $36.8 million in 2021, then increased by 11.61% to $41.1 million in 2022, then surged by 49.41% to $61.4 million in 2023, then increased by 23.03% to $75.6 million in 2024.
  • According to Business Quant data, Common Equity over the past three periods came in at $75.6 million, $61.4 million, and $41.1 million for Q4 2024, Q4 2023, and Q4 2022 respectively.